Coulter Partners places Dr Adam Davenport as CSO at Concept Life Sciences

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for Concept Life Sciences and is pleased to announce the placement of Dr. Adam Davenport as Chief Scientific Officer (CSO).

Concept Life Sciences is a leading global contract research organization (CRO) specializing in integrated drug discovery, development, and analytical services. The company provides consultative and collaborative solutions that enable biotech and pharmaceutical partners to navigate the complexities of translating innovations into viable therapeutics.

As CSO, Dr. Davenport will spearhead the company’s integrated drug discovery offering. A seasoned "drug hunter" with over 25 years of experience, he brings an exceptional track record of moving complex programs from initial concept through to clinical evaluation. His appointment reinforces the company’s commitment to providing world-class scientific leadership to its global collaborators.

Jonathan Critchley, Interim CEO of Concept Life Sciences, commented:

We are delighted to welcome Adam to the team. His passion for science, track record in delivering clinical quality assets, and proven ability to lead multi-disciplinary teams across the UK, Europe, and the US - will be invaluable as we continue to expand our integrated discovery facilities and deliver valuable inflection points for our global clients. We appreciated the close partnership with Coulter Partners throughout this critical search. Their team demonstrated a deep understanding of the high-level scientific leadership required to drive our strategy, and their global reach was instrumental in securing a leader of Adam’s standing.

Kay Wardle, Managing Partner at Coulter Partners, added:

It has been a privilege to partner with the team at Concept Life Sciences to secure such a distinguished scientific leader. Adam’s deep expertise across innovative modalities – including targeted protein degradation and covalent drug discovery – makes him the perfect fit to drive the company’s mission forward. We are proud to support Concept Life Sciences as the organization takes the next step in its journey to become a leading fully integrated CRO.